Venmax Drugs and Pharmaceuticals Ltd — Important, 14-04-2026: Company Update

Venmax Drugs & Pharmaceuticals has confirmed its regulatory compliance for the quarter ended March 31, 2026. The company submitted a certificate from its Registrar and Share Transfer Agent, CIL Securities Limited, verifying that all share transfer and dematerialization requests from investors were processed correctly and promptly. This update demonstrates the company's commitment to maintaining accurate shareholder records and meeting its market obligations, which is crucial for investor confidence.